AlzeCure Pharma AB (publ) (STO:ALZCUR)
5.68
-0.16 (-2.74%)
Nov 20, 2026, 5:29 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 783.26 million as of November 20, 2026. It is the 26,415th most valuable company in the world and the 331st biggest in Sweden. Its market cap has increased by 237.43% in one year.
Market Cap
783.26M
Enterprise Value
553.04M
Revenue
163.52M
Global Rank
Country Rank
#331 Sweden
PE Ratio
7.36
ChartMarket Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has increased from 415.42M to 783.26M, an increase of 88.54%. That is a compound annual growth rate of 8.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 783.26M | 240.80% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.55B |
| Genovis AB (publ.) | 1.53B |
| Flerie AB | 1.08B |
| Infant Bacterial Therapeutics AB | 934.92M |
| SynAct Pharma AB | 727.98M |
| Medivir AB | 651.64M |
| Oncopeptides AB | 648.27M |
| Xspray Pharma AB | 482.70M |